Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M86.2Revenue $M20.9Net Margin (%)-117.7Altman Z-Score-8.8
Enterprise Value $M78.0EPS $-1.3Operating Margin %-106.2Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.4Pre-tax Margin (%)-117.9Higher ROA y-yN
Price/Book3.910-y EBITDA Growth Rate %--Quick Ratio1.7Cash flow > EarningsY
Price/Sales3.45-y EBITDA Growth Rate %--Current Ratio1.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-52.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-140.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M20.2ROIC % (ttm)-155.2Gross Margin Increase y-yY

Gurus Latest Trades with CRME

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CRMEJulian Robertson 2012-12-31 Sold Out -0.11%$1.25 - $2.5
($1.57)
$ 4.28173%Sold Out0
CRMEJulian Robertson 2011-12-31 Reduce-0.48%$9.35 - $17.85
($13.05)
$ 4.28-67%Reduce -18.26%319,221
CRMEGeorge Soros 2011-12-31 Sold Out -0.0008%$9.35 - $17.85
($13.05)
$ 4.28-67%Sold Out0
CRMEJulian Robertson 2011-09-30 Reduce-0.69%$16.45 - $27.95
($19.94)
$ 4.28-79%Reduce -22.89%390,518
CRMEGeorge Soros 2011-09-30 Add$16.45 - $27.95
($19.94)
$ 4.28-79%Add 4.55%2,760
CRMEGeorge Soros 2011-06-30 Buy $19.25 - $28.85
($23.62)
$ 4.28-82%New holding2,640
CRMEJulian Robertson 2011-03-31 Add0.16%$21.3 - $34.95
($29.35)
$ 4.28-85%Add 6.15%506,468
CRMEJulian Robertson 2010-12-31 Add0.34%$23 - $32.75
($27.98)
$ 4.28-85%Add 9.55%477,123
CRMEGeorge Soros 2010-12-31 Sold Out $23 - $32.75
($27.98)
$ 4.28-85%Sold Out0
CRMEJulian Robertson 2010-09-30 Add0.4%$29.85 - $46.55
($36.3)
$ 4.28-88%Add 10.01%435,523
CRMEGeorge Soros 2010-09-30 Reduce$29.85 - $46.55
($36.3)
$ 4.28-88%Reduce -3.67%2,100
CRMEJulian Robertson 2010-06-30 Buy 3.53%$33.05 - $43.4
($40.05)
$ 4.28-89%New holding395,881
CRMEGeorge Soros 2010-06-30 Buy $33.05 - $43.4
($40.05)
$ 4.28-89%New holding2,180
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CRME is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CRME: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Archibald, JenniferSenior Officer 2014-09-08Buy75$7.29-41.29view
Archibald, JenniferSenior Officer 2014-09-05Buy4,100$7.25-40.97view
Archibald, JenniferSenior Officer 2014-09-05Buy100$7.22-40.72view
Archibald, JenniferSenior Officer 2014-09-05Buy3,259$6.7-36.12view
Hunter, William L.Director, Senior Officer 2014-09-05Buy31,000$6.74-36.5view
Hunter, William L.Director, Senior Officer 2014-09-04Buy19,000$6.65-35.64view
RIEDER, ROBERTDirector, Director or Senior Officer of Insider or 2014-06-27Sell2,000$8.65-50.52view
RIEDER, ROBERTDirector, Director or Senior Officer of Insider or 2014-06-26Sell1,500$8.65-50.52view
RIEDER, ROBERTDirector, Director or Senior Officer of Insider or 2014-06-25Sell300$8.63-50.41view
RIEDER, ROBERTDirector, Director or Senior Officer of Insider or 2014-06-25Sell2,000$8.64-50.46view

Press Releases about CRME :

Quarterly/Annual Reports about CRME:

    News about CRME:

    Articles On GuruFocus.com
    A Closer Look Into Veritas Pharma Apr 21 2016 
    Julian Robertson’s "smart idea, grounded on exhaustive research, followed by a big bet" Jun 24 2011 
    Julian Robertson’s Tiger Management Q1 Portfolio Update May 16 2011 
    Julian Robertson Keeps Buying CRME, Selling AAPL Apr 13 2011 
    More Word of Wisdom from Julian Robertson; Top 2Q10 Purchases: GOOG, EBAY, AAPL, CRME, GS Nov 04 2010 

    More From Other Websites
    Cardiome to Present at the Bloom Burton & Co. 5th Annual Healthcare Investor Conference Apr 28 2016
    Cardiome to Present at the Bloom Burton & Co. 5th Annual Healthcare Investor Conference Apr 28 2016
    Cardiome to Present at the Bloom Burton & Co. 5th Annual Healthcare Investor Conference Apr 28 2016
    New Strong Sell Stocks for April 25th Apr 25 2016
    A Closer Look Into Veritas Pharma Apr 21 2016
    New Strong Sell Stocks for April 14th Apr 14 2016
    CARDIOME PHARMA CORP Financials Apr 07 2016
    Cardiome Announces Publication of Independent Study Comparing BRINAVESS to IBUTILIDE in Patients... Mar 31 2016
    Cardiome Announces Publication of Independent Study Comparing BRINAVESS to Ibutilide in Patients... Mar 31 2016
    Cardiome Announces Publication of Independent Study Comparing BRINAVESS to Ibutilide in Patients... Mar 31 2016
    New Strong Sell Stocks for March 29th Mar 29 2016
    Fairholme Cuts Stake in Sears Holdings Corp (SHLD), Ubben Sells Even More Shares of Motorola... Mar 23 2016
    Cardiome Pharma Corp. :CRME-US: Earnings Analysis: Q4, 2015 By the Numbers Mar 21 2016
    New Strong Sell Stocks for March 21st Mar 21 2016
    Cardiome reports 4Q loss Mar 10 2016
    Cardiome reports 4Q loss Mar 10 2016
    Cardiome Reports Fourth Quarter and Full Year 2015 Financial Results Mar 10 2016
    Cardiome Reports Fourth Quarter and Full Year 2015 Financial Results Mar 10 2016
    Cardiome Announces Filing of Prospectus Supplements Mar 07 2016
    Cardiome Announces Filing of Prospectus Supplements Mar 07 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)